Mindblown: a blog about philosophy.

New Positive Study Results Published in Clinical Cancer Research BOULDER, CO, July 16, 2020 – Biodesix, Inc., a leader in lung cancer diagnostics, announced the publication of research findings on a diagnostic test capable of generating valuable data to help guide the treatment of patients with advanced non-small cell lung cancer (NSCLC). The paper, entitled…

BOSTON & BOULDER, CO, July 13, 2019 – Major League Lacrosse (MLL) today announced a partnership with Biodesix, Inc., whereby Biodesix will be the exclusive provider of COVID-19 testing for the upcoming 2020 MLL season. “The health and safety of our players, coaches, and staff is the number one priority for the 2020 Major League…

Range of Testing Solutions Aimed at Helping Businesses Safely Resume Work Operations BOULDER, CO, June 8, 2020 – Biodesix, Inc., a leading diagnostic company in lung disease, announced today that it has launched the Biodesix WorkSafe™ Program, a customized return to work service for employers. The program is designed to help all businesses in the…

Clinical Data Offer Meaningful Diagnostic Information for Patients in the Lung Cancer Continuum of Care BOULDER, CO, May 27, 2020 – Biodesix, Inc., a leading diagnostic company in lung disease, recently published three clinical research abstracts, which reported valuable new information regarding treatment of patients in the lung cancer continuum of care. The data from…

Drive-up Testing Sites Offer Appointments for Patients BOULDER, CO, May 19, 2020 – Biodesix, Inc., a leading diagnostic company in lung disease, announced today that it has partnered with Boulder Community Health (BCH), a community owned-and-operated not-for-profit health system, to offer expanded COVID-19 testing in the greater Boulder, CO area. The Biodesix SARS-CoV-2 ddPCR™ Test…

COVID-19 Antibody Tests Are Key in Understanding Infection and Immunity Rates BOULDER, CO, May 19, 2020 -Biodesix, Inc., a leading diagnostic company in lung disease, today announced that it has collaborated with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to launch a blood-based immunoassay-based test that identifies antibodies to SARS-CoV-2, the virus that causes COVID-19.…

Droplet Digital™ PCR Test Offered for Detection of SARS-CoV-2 BOULDER, CO, April 8, 2020 -Biodesix, Inc., a leading diagnostic company in lung disease, today announced that it began SARS-CoV-2 Droplet Digital PCR (ddPCR) testing for the virus that causes COVID-19 and will immediately submit for Emergency Use Authorization from the Food and Drug Administration. Initially,…